Elizabeth H. Baldini, MD, MPH, William G. Richards, PhD, Ritu R

Slides:

Advertisements

Similar presentations

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non–small cell lung cancer Kamran.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

“Lead from the front”: Participative leadership

Philip A. Linden, MD, Richard J. Gilbert, MD, Beow Y

Ground glass opacity of the lung: The veil that needs lifting

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

How should we treat air leaks?

Go on-pump or off-pump in diabetic patients?

What is the best approach for surgery of malignant pleural mesothelioma? It is to put our efforts into obtaining trustworthy evidence for practice Tom.

Commentary: Pursuit of the green jacket: Mastery of the long and short games Daniel P. Raymond, MD The Journal of Thoracic and Cardiovascular Surgery

The lord of the rings Antonio Miceli, MD, PhD

Is tissue the issue? Brian E. Louie, MD, MHA, MPH, FRCSC, FACS

The variability of the mitral valve anatomy and terminology

Yang Zhang, MD, Haiquan Chen, MD, PhD

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Management of stage IIIA (N2) non–small cell lung cancer: A transatlantic perspective Gaetano Rocco, MD, Katie Nason, MD, MPH, Alex Brunelli, MD, Gonzalo.

Military surgeons just want to have fun

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Stephen R. Broderick, MD, MPHS

Shawn S. Groth, MD, MS, R. Taylor Ripley, MD, Bryan M. Burt, MD

Characteristics of Malignant Pleural Mesothelioma in Women

The Journal of Thoracic and Cardiovascular Surgery

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Replicating the success of mitral valve repair in the aortic valve

Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: Result in a cohort of 203 resection specimens Aneil.

The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the.

Frank C. Spencer, MD, FACS, pioneering cardiothoracic surgeon

Attachment disorder in thoracoabdominal surgery

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Prognosis and “granularity”: Building on staging foundations?

Functional tricuspid pathology: To treat or not to treat

First nights, the adrenal axis, and steroids

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural.

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

The continuing challenge of congenital heart disease in China

After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10% Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular.

Therapeutic R2 resection for pleural mesothelioma

“The more things change…”: The challenges ahead

Why arch curvature affects arch resistance

Junaid Haroon, MD, Subroto Paul, MD, MPH

Managing conflicts of interest

Aritoshi Hattori, MD, Kenji Suzuki, MD

More than vital: Who bears the burden?

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

American College of Cardiology/American Heart Association 2016 dual antiplatelet therapy (DAPT) focused update: Implications for surgeons Richard J.

Who should decide margin length in pulmonary excision of lung cancer?

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Journal changes and initiatives

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Akiko Tanaka, MD, PhD, Takeyoshi Ota, MD, PhD

Deciding how much to pay for effective care

Presentation transcript:

Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma Elizabeth H. Baldini, MD, MPH, William G. Richards, PhD, Ritu R. Gill, MD, MPH, Brian M. Goodman, MD, Olivia K. Winfrey, MPH, Hannah M. Eisen, MS, Raymond H. Mak, MD, Aileen B. Chen, MD, MPP, David E. Kozono, MD, PhD, Raphael Bueno, MD, David J. Sugarbaker, MD The Journal of Thoracic and Cardiovascular Surgery Volume 149, Issue 5, Pages 1374-1381 (May 2015) DOI: 10.1016/j.jtcvs.2014.10.128 Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Percentage of patients with first site of recurrence in IHT, CHT, abdomen, and mediastinum according to the American Joint Committee on Cancer stage. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 1374-1381DOI: (10.1016/j.jtcvs.2014.10.128) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Sites of first failure for 158 patients in current cohort compared with previous cohort. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 1374-1381DOI: (10.1016/j.jtcvs.2014.10.128) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions